Phase 2 Trial Will Assess Autologous Mesenchymal Stem Cell Therapy to Treat Progressive Forms of MS

Phase 2 Trial Will Assess Autologous Mesenchymal Stem Cell Therapy to Treat Progressive Forms of MS

Publication date: Mar 13, 2019

This post was originally published on this site The National Multiple Sclerosis Society is funding a new Phase 2 clinical trial to test the effectiveness of stem cell therapy on individuals with progressive forms of multiple sclerosis (MS), using mesenchymal stem cells from their own bone marrow. Once mesenchymal stem cells are infused, they are believed to secrete growth factors that stimulate the repair of damaged tissues, and possibly act as inhibitors of immune responses associated with MS. The placebo-controlled, Phase 2 trial will test the effectiveness of autologous cell therapy with mesenchymal stem cells-neural progenitors in 50 participants with progressive forms of MS. Participants will receive six injections of culture-expanded autologous stem cells at two month intervals in one year. The post Phase 2 Trial Will Assess Autologous Mesenchymal Stem Cell Therapy to Treat Progressive Forms of MS appeared first on Multiple Sclerosis News Today. The post Phase 2 Trial Will Assess Autologous Mesenchymal Stem Cell Therapy to Treat Progressive Forms of MS appeared first on BioNewsFeeds.

Concepts Keywords
Autologous Stem cells
Bebo Stem-cell therapy
Bladder Draft:BrainStorm Cell Therapeutics
Bone Marrow Bone marrow
Clinical Trial Developmental biology
Clinical Trials Mesenchymal stem cell
Disability Regenerative biomedicine
Growth Factors Biotechnology
Mesenchymal Cell biology
Mesenchymal Stem Cell Stem cells
Mesenchymal Stem Cells Life sciences
Multiple Sclerosis Branches of biology
Multipotent MS
PhD
Placebo
Progressive
Spinal Fluid

Semantics

Type Source Name
drug DRUGBANK Nonoxynol-9
pathway BSID Release
gene UNIPROT PDC
gene UNIPROT BIRC6
disease MESH growth
disease MESH multiple
drug DRUGBANK Mesenchymal Stem Cells
disease DOID Multiple Sclerosis
disease MESH Multiple Sclerosis
gene UNIPROT SLC35G1

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *